Gardasil 9 syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJH6D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,496
Award facts
- Contract value 100% obligated
- $41,496.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 13, 2026, the Defense Logistics Agency awarded a $41,496.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 Syringe 0.5ML, a human papillomavirus vaccine. The contract is non-competitive with no small business set-aside and is scheduled for completion by January 14, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as the prime contractor. The award represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
This delivery order reflects the Defense Logistics Agency's ongoing efforts to maintain adequate pharmaceutical inventory for military treatment facilities and veteran healthcare systems. AmerisourceBergen Drug Corp's parent company, Cencora, Inc., operates as a critical pharmaceutical distributor for federal agencies and holds the underlying Indefinite Delivery Contract with DLA. The vaccine supply chain managed through such contract vehicles is essential to military medical readiness and the healthcare operations of the Defense Health Agency and affiliated government medical institutions.
Quick answers
Who was awarded contract SPE2DR26FJH6D?
SPE2DR26FJH6D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FJH6D worth?
The government has obligated $41,496 on SPE2DR26FJH6D.
Is contract SPE2DR26FJH6D an order under another contract?
Yes. SPE2DR26FJH6D is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH6D competed?
The extent of competition for SPE2DR26FJH6D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award